Objective To explore the dosimetric difference between different radiotherapytechnologies in the treatment of early peripheral stage non-small-cell lung cancer (NSCLC). Methods
Four-dimensional computed tomography scans and delineation of target volumes and organs at risk (OARs) were performed in 5 patients pathologically diagnosed with stage T1/T2 peripheral NSCLC who were admitted from 2014 to 2015. Target volumes contained gross tumor volume (GTV), internal target volume (ITV), and planning target volume (PTV). ITV was contoured on the maximum intensity projection images. PTV was defined as ITV plus a 5 mm margin. OARs contained the heart, lung, esophagus, and spinal cord. The Monaco 5.0 treatment planning system was used to design three plans. The three-dimensional conformal radiotherapy (3DCRT) plan had 11 fields in the diseased lung covering the PTV plus a 0.2 cm margin. The sliding window intensity-modulated radiotherapy (SW-IMRT) plan had 9 fields in the same areas as the 3DCRT plan. The volumetric modulated arc therapy (VMAT) plan had the gantry rotating 180° around the diseased lung. The evaluation criteria referred to the RTOG 0618 trial. Comparison was made by paired t test. Results The SW-IMRT plan had a significantly better homogeneity index than the 3DCRT plan (1.03 vs. 1.24,P=0.017). Compared with the VMAT plan, the mean monitor units in the 3DCRT plan was significantly reduced by 24.5%(P=0.022). The V30 and V40 of the 3DCRT plan were significantly reduced by 29.4% and 28.4%, respectively, compared with the SW-IMRT plan (P=0.003,0.006) and 56.7% and 59.7%, respectively, compared with the VMAT plan (P=0.041,0.019). Conclusions 3DCRT may be an appropriate radiotherapy method for early stage NSCLC.
Guo Yuexin,Wang Haiyang,Liu Lele et al. Analysis of the dosimetry differences between peripheral early stage non-small cell lung cancer (NSCLC) treated with SBRT technique[J]. Chinese Journal of Radiation Oncology, 2017, 26(1): 62-65.
Guo Yuexin,Wang Haiyang,Liu Lele et al. Analysis of the dosimetry differences between peripheral early stage non-small cell lung cancer (NSCLC) treated with SBRT technique[J]. Chinese Journal of Radiation Oncology, 2017, 26(1): 62-65.
[1] Louie AV,Rodrigues G,Hannouf M,et al. Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer:a Markov model-based decision analysis[J].Int J Radiat Oncol Biol Phys,2011,81(4):964-973.DOI:10.1016/j.ijrobp.2010.06.040.
[2] Jones AO,Das IJ.Comparison of inhomogeneity correction algorithms in small photon fields[J].Med Phys,2005,32(3):766-776.DOI:10.1118/1.1861154.
[3] Bortfeld T,Jokivarsi K,Goitein M,et al. Effects of intra-fraction motion on IMRT dose delivery:statistical analysis and simulation[J].Phys Med Biol,2002,47(13):2203-2220.DOI:10.1088/0031-9155/47/13/302.
[4] Ginsberg RJ,Rubinstein LV.Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Lung Cancer Study Group[J].Ann Thorac Surg,1995,60(3):615-622.DOI:10.1016/0003-4975(95)00537-U.
[5] Mountain CF.A new international staging system for lung cancer[J].Chest,1986,89(4S):225S-233S.DOI:10.1378/chest.89.4_Supplement.225S.
[6] Naruke T,Goya T,Tsuchiya R,et al. Prognosis and survival in resected lung carcinoma based on the new international staging system[J].J Thorac Cardiovasc Surg,1988,96(3):440-447.
[7] Grills IS,Mangona VS,Welsh R,et alOutcomes after stereotactic lung radiotherapy or wedge resection for stage Ⅰ non-small-cell lung cancer[J].J Clin Oncol,2010,28(6):928-935.DOI:10.1200/JCO.2009.25.0928.
[8] Jiwnani S,Karimundackal G,Pramesh CS.Stereotactic radiotherapy versus sublobar lung resection in medically unfit patients with early-stage non-small-cell lung cancer[J].J Clin Oncol,2010,28(29):e569-e570.DOI:10.1200/JCO.2010.29.4108.
[9] Matuszak MM,Yan D,Grills I,et al. Clinical applications of volumetric modulated arc therapy[J].Int J Radiat Oncol Biol Phys,2010,77(2):608-616.DOI:10.1016/j.ijrobp.2009.08.032.
[10] Diot Q,Kavanagh B,Timmerman R,et al. Biological-based optimization and volumetric modulated arc therapy delivery for stereotactic body radiation therapy[J].Med Phys,2012,39(1):237-245.DOI:10.1118/1.3668059.
[11] Wang SL,Liao ZX,Wei X,et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT)[J].Int J Radiat Oncol Biol Phys,2006,66(5):1399-1407.DOI:10.1016/j.ijrobp.2006.07.1337.
2017, Vol. 26 
